American Caresource Competitors

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and American Caresource (OTCMKTS:GNOW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for Fresenius Medical Care AG & Co. KGaA and American Caresource, as provided by MarketBeat.

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $45.00, suggesting a potential upside of 19.43%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than American Caresource.

Profitability

This table compares Fresenius Medical Care AG & Co. KGaA and American Caresource's net margins, return on equity and return on assets.

Insider and Institutional Ownership

1.6% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 51.5% of American Caresource shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Fresenius Medical Care AG & Co. KGaA and American Caresource's revenue, earnings per share and valuation.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than American Caresource.

Volatility & Risk

Fresenius Medical Care AG & Co. KGaA has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, American Caresource has a beta of 2.56, indicating that its stock price is 156% more volatile than the S&P 500.

Summary

Fresenius Medical Care AG & Co. KGaA beats American Caresource on 7 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and DaVita (NYSE:DVA) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and DaVita, as reported by MarketBeat.com.

DaVita has a consensus price target of $114.60, suggesting a potential upside of 5.89%. Given DaVita's higher probable upside, analysts plainly believe DaVita is more favorable than American Caresource.

Profitability

This table compares American Caresource and DaVita's net margins, return on equity and return on assets.

Institutional and Insider Ownership

91.7% of DaVita shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 1.0% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares American Caresource and DaVita's top-line revenue, earnings per share and valuation.

DaVita has higher revenue and earnings than American Caresource.

Volatility and Risk

American Caresource has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, DaVita has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

Summary

DaVita beats American Caresource on 7 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and Sotera Health (NYSE:SHC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and Sotera Health, as reported by MarketBeat.com.

Sotera Health has a consensus price target of $32.75, suggesting a potential upside of 26.30%. Given Sotera Health's higher probable upside, analysts plainly believe Sotera Health is more favorable than American Caresource.

Profitability

This table compares American Caresource and Sotera Health's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares American Caresource and Sotera Health's top-line revenue, earnings per share and valuation.

Summary

Sotera Health beats American Caresource on 2 of the 2 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and Progyny, as reported by MarketBeat.com.

Progyny has a consensus price target of $38.8333, suggesting a potential downside of 22.10%. Given Progyny's higher probable upside, analysts plainly believe Progyny is more favorable than American Caresource.

Profitability

This table compares American Caresource and Progyny's net margins, return on equity and return on assets.

Institutional and Insider Ownership

58.5% of Progyny shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 33.3% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares American Caresource and Progyny's top-line revenue, earnings per share and valuation.

American Caresource has higher earnings, but lower revenue than Progyny.

Volatility and Risk

American Caresource has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500.

Summary

Progyny beats American Caresource on 7 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and Tivity Health (NASDAQ:TVTY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Volatility and Risk

American Caresource has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, Tivity Health has a beta of 2.49, suggesting that its share price is 149% more volatile than the S&P 500.

Profitability

This table compares American Caresource and Tivity Health's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and Tivity Health, as reported by MarketBeat.com.

Tivity Health has a consensus price target of $22.1250, suggesting a potential downside of 5.33%. Given Tivity Health's higher probable upside, analysts plainly believe Tivity Health is more favorable than American Caresource.

Valuation & Earnings

This table compares American Caresource and Tivity Health's top-line revenue, earnings per share and valuation.

American Caresource has higher earnings, but lower revenue than Tivity Health.

Institutional and Insider Ownership

91.6% of Tivity Health shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 11.8% of Tivity Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Tivity Health beats American Caresource on 6 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and SOC Telemed (NASDAQ:TLMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk and institutional ownership.

Profitability

This table compares American Caresource and SOC Telemed's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and recommmendations for American Caresource and SOC Telemed, as reported by MarketBeat.

SOC Telemed has a consensus price target of $11.40, suggesting a potential upside of 67.89%. Given SOC Telemed's higher probable upside, analysts clearly believe SOC Telemed is more favorable than American Caresource.

Earnings and Valuation

This table compares American Caresource and SOC Telemed's top-line revenue, earnings per share and valuation.

Institutional & Insider Ownership

20.7% of SOC Telemed shares are owned by institutional investors. 51.5% of American Caresource shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

SOC Telemed beats American Caresource on 3 of the 4 factors compared between the two stocks.